Compare BWA & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BWA | RVTY |
|---|---|---|
| Founded | 1987 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Laboratory Analytical Instruments |
| Sector | Consumer Discretionary | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.2B | 11.8B |
| IPO Year | 1995 | 1994 |
| Metric | BWA | RVTY |
|---|---|---|
| Price | $57.04 | $86.67 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 16 |
| Target Price | $59.33 | ★ $109.67 |
| AVG Volume (30 Days) | ★ 1.5M | 934.4K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.25% | 0.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | 1.28 | ★ 2.07 |
| Revenue | ★ $14,316,000,000.00 | $3,311,822,000.00 |
| Revenue This Year | $1.54 | $6.37 |
| Revenue Next Year | $3.54 | $5.10 |
| P/E Ratio | $44.52 | ★ $41.98 |
| Revenue Growth | ★ 1.63 | N/A |
| 52 Week Low | $28.92 | $81.22 |
| 52 Week High | $70.08 | $118.30 |
| Indicator | BWA | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 59.39 | 44.87 |
| Support Level | $51.43 | $83.22 |
| Resistance Level | $70.08 | $88.60 |
| Average True Range (ATR) | 1.46 | 3.45 |
| MACD | 0.13 | -0.68 |
| Stochastic Oscillator | 88.62 | 33.94 |
BorgWarner is a tier one supplier of turbo and thermal management technologies, drivetrain systems, powerdrive systems, and battery and charging systems mostly to automotive original equipment manufacturers. Its products aim to move a vehicle with as few electrons as possible, resulting in cleaner, cost-optimized, and more-efficient vehicles. Foundational products, the combustion vehicle business, contributes more than 80% to group revenue while BorgWarner transitions to becoming an electric vehicle-centric parts supplier (e-business). In 2024, 23% of the company's revenue was sourced from Volkswagen and Ford. Revenue is well diversified geographically, with approximately a third each generated in North America, Europe, and Asia.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.